These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23134735)

  • 1. Development and validation of a high-throughput intrinsic ATPase activity assay for the discovery of MEKK2 inhibitors.
    Ahmad S; Hughes MA; Johnson GL; Scott JE
    J Biomol Screen; 2013 Apr; 18(4):388-99. PubMed ID: 23134735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and characterization of an iminocoumarin scaffold as an inhibitor of MEKK2 (MAP3K2).
    Ahmad S; St Hilaire VR; Dandepally SR; Johnson GL; Williams AL; Scott JE
    Biochem Biophys Res Commun; 2018 Jan; 496(1):205-211. PubMed ID: 29309787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of ponatinib and other known kinase inhibitors with potent MEKK2 inhibitory activity.
    Ahmad S; Johnson GL; Scott JE
    Biochem Biophys Res Commun; 2015 Aug; 463(4):888-93. PubMed ID: 26056008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three mechanistically distinct kinase assays compared: Measurement of intrinsic ATPase activity identified the most comprehensive set of ITK inhibitors.
    Kashem MA; Nelson RM; Yingling JD; Pullen SS; Prokopowicz AS; Jones JW; Wolak JP; Rogers GR; Morelock MM; Snow RJ; Homon CA; Jakes S
    J Biomol Screen; 2007 Feb; 12(1):70-83. PubMed ID: 17166826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of MEKK2/3 serine phosphorylation site targeted by the Toll-like receptor and stress pathways.
    Zhang D; Facchinetti V; Wang X; Huang Q; Qin J; Su B
    EMBO J; 2006 Jan; 25(1):97-107. PubMed ID: 16362041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MEKK2 mediates aberrant ERK activation in neurofibromatosis type I.
    Bok S; Shin DY; Yallowitz AR; Eiseman M; Cung M; Xu R; Li N; Sun J; Williams AL; Scott JE; Su B; Shim JH; Greenblatt MB
    Nat Commun; 2020 Nov; 11(1):5704. PubMed ID: 33177525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of calpain-dependent degradation of STK38 by MEKK2-mediated phosphorylation.
    Enomoto A; Fukasawa T; Tsumoto H; Karube M; Nakagawa K; Yoshizaki A; Sato S; Miura Y; Miyagawa K
    Sci Rep; 2019 Nov; 9(1):16010. PubMed ID: 31690749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium regulation of EGF-induced ERK5 activation: role of Lad1-MEKK2 interaction.
    Yao Z; Yoon S; Kalie E; Raviv Z; Seger R
    PLoS One; 2010 Sep; 5(9):e12627. PubMed ID: 20830310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MEKK2 mediates an alternative β-catenin pathway that promotes bone formation.
    Greenblatt MB; Shin DY; Oh H; Lee KY; Zhai B; Gygi SP; Lotinun S; Baron R; Liu D; Su B; Glimcher LH; Shim JH
    Proc Natl Acad Sci U S A; 2016 Mar; 113(9):E1226-35. PubMed ID: 26884171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assays, surrogates, and alternative technologies for a TB lead identification program targeting DNA gyrase ATPase.
    Humnabadkar V; Madhavapeddi P; Basavarajappa H; Sheikh MG; Rane R; Basu R; Verma P; Sundaram A; Mukherjee K; de Sousa SM
    J Biomol Screen; 2015 Feb; 20(2):265-74. PubMed ID: 25300873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Semi-High-Throughput Adaptation of the NADH-Coupled ATPase Assay for Screening Small Molecule Inhibitors.
    Radnai L; Stremel RF; Sellers JR; Rumbaugh G; Miller CA
    J Vis Exp; 2019 Aug; (150):. PubMed ID: 31475972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MEKK2 inhibits activation of MAP kinases in Arabidopsis.
    Nitta Y; Qiu Y; Yaghmaiean H; Zhang Q; Huang J; Adams K; Zhang Y
    Plant J; 2020 Jul; 103(2):705-714. PubMed ID: 32267570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase C alpha, betaI, and betaII isozymes regulate cytokine production in mast cells through MEKK2/ERK5-dependent and -independent pathways.
    Li G; Lucas JJ; Gelfand EW
    Cell Immunol; 2005 Nov; 238(1):10-8. PubMed ID: 16430878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a high-throughput screening method for LIM kinase 1 using a luciferase-based assay of ATP consumption.
    Mezna M; Wong AC; Ainger M; Scott RW; Hammonds T; Olson MF
    J Biomol Screen; 2012 Apr; 17(4):460-8. PubMed ID: 22156225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A High-Throughput Genetic Complementation Assay in Yeast Cells Identified Selective Inhibitors of Sphingosine Kinase 1 Not Found Using a Cell-Free Enzyme Assay.
    Kashem MA; Kennedy CA; Fogarty KE; Dimock JR; Zhang Y; Sanville-Ross ML; Skow DJ; Brunette SR; Swantek JL; Hummel HS; Swindle J; Nelson RM
    Assay Drug Dev Technol; 2016; 14(1):39-49. PubMed ID: 26426296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dimerization through the catalytic domain is essential for MEKK2 activation.
    Cheng J; Yu L; Zhang D; Huang Q; Spencer D; Su B
    J Biol Chem; 2005 Apr; 280(14):13477-82. PubMed ID: 15695508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A bioluminogenic HDAC activity assay: validation and screening.
    Halley F; Reinshagen J; Ellinger B; Wolf M; Niles AL; Evans NJ; Kirkland TA; Wagner JM; Jung M; Gribbon P; Gul S
    J Biomol Screen; 2011 Dec; 16(10):1227-35. PubMed ID: 21832257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-Based Design of a Novel SMYD3 Inhibitor that Bridges the SAM-and MEKK2-Binding Pockets.
    Van Aller GS; Graves AP; Elkins PA; Bonnette WG; McDevitt PJ; Zappacosta F; Annan RS; Dean TW; Su DS; Carpenter CL; Mohammad HP; Kruger RG
    Structure; 2016 May; 24(5):774-781. PubMed ID: 27066749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homogeneous single-label tyrosine kinase activity assay for high throughput screening.
    Tong-Ochoa N; Kopra K; Syrjänpää M; Legrand N; Härmä H
    Anal Chim Acta; 2015 Oct; 897():96-101. PubMed ID: 26515010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Inhibitors by Ligand-based Virtual High Throughput Screening.
    Selvam C; Mock CD; Mathew OP; Ranganna K; Thilagavathi R
    Mol Inform; 2020 Jul; 39(7):e1900150. PubMed ID: 32147949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.